loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 95f4b2ad 2c58 470f A227 B0096c0f84fa Applno 204629 Form Tablet Oral Dosage 25mg - Drug Product Composition: (2S,3R,4R,5S,6R)-2-[4-CHLORO-3-[[4-[(3S)-OXOLAN-3-YL]OXYPHENYL]METHYL]PHENYL]-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL

    Menu

    (2S,3R,4R,5S,6R)-2-[4-CHLORO-3-[[4-[(3S)-OXOLAN-3-YL]OXYPHENYL]METHYL]PHENYL]-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,782Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 204629 / DOSAGE - TABLET;ORAL - 25MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    EMPAGLIFLOZIN(UNII: HDC1R2M35U)
    (EMPAGLIFLOZIN - UNII:HDC1R2M35U)     		EMPAGLIFLOZIN10mg